Research Center

The team of SphinxCure has published lots of medical papers and research in the field of oncology and the following is some of them. Moreover, the centre is pleased to welcome Junior oncologists in need to continue their medical thesis and research in Oncology and provide them with the latest journals, researches and clinical trials.
The centre also provide through through the membership with the American & European Society of Medical Oncology (ASCO & ESMO) a direct access to the latest information to meet up with the patients' needs from all aspects.
For that, the centre is in continuous professional contact with the most qualified French colleagues in Paris through the best reference Oncology centers in France.

---

Examples of the medical research conducted:

• Results of Erlotinib in previously treated Egyptian patients with non small cell lung cancer.
• Imatinib in metastatic or unresectable gastro intestinal stromal tumors.
• The effect of EGFR over-expression in inoperable non small cell lung cancer (NSCLC) patients receiving Cisplatin-Vinorelbine combination.
• Long term treatment outcome of low grade gliomas.
• Role of FISH analysis in the prediction of treatment outcome in adult patients with de novo AML.
• Cisplatin plus Gemcitabine in patient with inoperable or metastatic pancreatic cancer.
• Prognostic significance of pre-operative Radiochemotherapy in rectal cancer.
• Palliative fractionated radiotherapy for bone metastasis, clinical and biological assessment of single versus multiple fractions.
• The efficacy and toxicity of Oxaliplatin, 5-Fluorouracil and Leucovorin as adjuvant treatment in patients with colon cancer.
• Comparative study analyzing survival and safety of Bevacizumab/Carboplatin/Paclitaxel versus Carboplatin/Docetaxel in initial treatment of metastatic Her-2- negative breast cancer.
• Comparative study analyzing survival and safety of Bevacizumab/Carboplatin/Paclitaxel and Cisplatin/Pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation.
• Prospective study evaluating the radiosensitizing effect of reduced doses of Temozolomide in the treatment of Egyptian patients with glioblastoma multiforme.
• Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens.
• Changes in Survival in locally advanced laryngeal carcinoma over past three decades.
• A descriptive study of plasma cell dyscrasias in Egyptian population.
• Palliative Chemotherapy in Recurrent or Metastatic Squamous cell carcinoma of the head and neck, NEMROCK experience.
• Epidemiological Evaluation of Colorectal Cancer with focus on young Age, NEMROCK experience.
• Palliative Metronomic Oral chemotherapy for salvage of Egyptian patients with metastatic breast cancer.